Herbalife’s quarterly sales rose 1.3%, the first rise after five quarters of decline, as demand increased for its health supplements in North America and China.
Separately, the company said that its talks with the U.S. Federal Trade Commission over its business practices were in advanced stages and it could face a payment of about $200 million, CNBC reported on Thursday.
Herbalife (HLF) shares surged nearly 14% in extended trading.
The company was not immediately available for comment on the CNBC report.
Herbalife‘s sales in China rose by nearly a third to $217.4 million in the first quarter. Sales in North America, its biggest market, increased 8.5%.
Herbalife, which said in March that a database error caused it to overstate new member growth over the past three quarters, also raised its adjusted profit forecast for the year ending Dec. 31 to $5.10-$5.45 per share from $4.85-$5.30.
For more on Herbalife, read Fortune’s feature The Seige of Herbalife.
Its net income rose 22.5% to $95.8 million, or $1.12 per share, in the quarter ended March 31.
Excluding items, the company earned $1.36 per share, beating the average analyst estimate of $1.09 per share, according to Thomson Reuters I/B/E/S.
Net sales increased to $1.12 billion, topping the average estimate of $1.07 billion.
Herbalife shares were trading at $66.30 after the bell.
